AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has submitted a compliance certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, issued by the company's Registrar and Transfer Agent (Integrated Registry Management Services), covers the period from April 1 to April 30, 2025. It confirms that physical share certificates received from depository participants were dematerialized, the original certificates were mutilated and cancelled, and the depository's name was recorded as the registered owner. This is a routine monthly compliance filing required under SEBI rules.
This is a standard procedural filing with no impact on shareholders, business operations, or stock price. It merely confirms the RTA followed proper protocol for processing share dematerialization requests during April 2025.